Trial Profile
Intranasal Mupirocin to Eliminate Carriage of Staphylococcus Aureus in HIV Infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2023
Price :
$35
*
At a glance
- Drugs Mupirocin (Primary)
- Indications Staphylococcal infections
- Focus Therapeutic Use
- Acronyms NOSE
- 07 Jan 2009 Primary endpoint 'Bacteriological colonisation rate' has been met.
- 09 Dec 2008 New trial record.
- 28 Oct 2008 Results have been presented at the 2008 ICAAC/IDSA.